Clinical Trial Update: An Extension Study Investigating the Efficacy and Safety of a Fast-Dissolving ("Melt") Formulation of Desmopressin for the Treatment of Nocturia in Adults [Phase 3]

View source ↗

Summary

This document reports results from an extension Phase 3 study evaluating the efficacy and safety of a fast-dissolving desmopressin melt formulation for treating…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Nocturia

Drugs mentioned

• Desmopressin fast-dissolving melt formulation (desmopressin acetate)

Snippet

Sponsor: Ferring Pharmaceuticals | Conditions: Nocturia | Phase 3 | Status: COMPLETED | Results posted: 2015-12-15